[ad_1]
July 2, 2018
In HIV-infected patients, cirrhosis but not chronic infection with hepatitis C virus (HCV) is badociated with an increased risk of diabetes mellitus, according to a multicenter study published in Alimentary Pharmacology & Therapeutics
French researchers prospectively followed 28,699 patients living with HIV for an average duration of 12.4 ± 7.9 years. Among these patients, 969 (3.4%) developed diabetes over an average period of 11.0 ± 6.4 years, giving a DM rate of 2.74 cases per 1000 person-years of follow-up.
Four thousand and four patients were co-infected with chronic HCV infection, and among these patients, 164 (4.1%) developed diabetes, which was a significantly higher rate than monoinfected patients with HIV. (4.1% vs. 3.2%, P <007). Old age, high body mbad index, AIDS status, a number of CD4 nadir cells ≤200 / mm 3 a detectable HIV viral load and cirrhosis are badociated with the development of DM, but HCV and chronic hepatitis B
Although a history of interferon-based anti-HCV treatment has not been badociated with DM development, a longer duration Antiretroviral combination therapy was badociated with a lower risk of DM
. "In conclusion, our study shows that in [patients living with HIV] cirrhosis is badociated with an increased risk of diabetes mellitus, but the prolonged virologic response does not appear to be related to the development of diabetes.", States the authors
Reference [19659010] Provoost A, Dramé M, Cotte L, et al., Study Group Dat & AIDS, Diabetes Risk in HIV-Infected Patients Associated with Cirrhosis, but not Co-Infection Chronic HCV in a French National HIV Cohort [published online June 14, 2018] Aliment Pharmacol Ther 2018. doi: 10.1111 / apt.14812
window.fbAsyncInit = function () { FB.init ({appId: & # 39; 1141987009185037 & # 39 ;, status: true, cookie: true, xfbml: true}); // subscribe fb "like" in Badgeville if (typeof AddBadgevilleShareBehavour == & # 39;) { FB.Event.subscribe (& # 39; edge.create & # 39 ;, function (answer) { AddBadgevilleShareBehavour (); }); } }
(function (d) { var js, id = facebook-jssdk, ref = d.getElementsByTagName (& quot; script & quot;) [0]; if (d.getElementById (id)) {return;} js = d.createElement (& # 39; script & # 39;); js.id = id; js.async = true; js.src = "http://connect.facebook.net/en_US/all.js"; ref.parentNode.insertBefore (js, ref); }(document));
$ .getScript (& # 39; https: //platform.twitter.com/widgets.js' ;, function () { // subscribe twitter share at Badgeville if (typeof AddBadgevilleShareBehavour == & # 39;) { twttr.events.bind (& # 39; tweet; function (event) { AddBadgevilleShareBehavour (); }); } });
(function () {
var po = document.createElement (& # 39; script & # 39;); po.type = text / javascript & # 39 ;; po.async = true;
po.src = & # 39; https: //apis.google.com/js/plusone.js' ;;
var s = document.getElementsByTagName ('script') [0]; s.parentNode.insertBefore (po, s);
}) ();
[ad_2]
Source link